GARRETT MUHLSTADT: Open Payments
NPI 1609496686 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 43 payments from 21 companies in 2025. Trend: 2023 $235 · 2024 $653 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $150 |
| Novo Nordisk Inc | 5 | $127 |
| GlaxoSmithKline, LLC. | 6 | $110 |
| Astellas Pharma US Inc | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Corium, LLC | 2 | $37 |
| Dexcom, Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| PFIZER INC. | 1 | $24 |
Products named: TRELEGY ELLIPTA, Rybelsus, VRAYLAR, QULIPTA, Wegovy, Veozah, CAPLYTA, Jornay PM.
Industry payments across IN — which companies pay providers there.
